Spero Therapeutics
SPRO
#9620
Rank
โ‚ฌ36.05 M
Marketcap
0,64ย โ‚ฌ
Share price
-0.70%
Change (1 day)
-52.39%
Change (1 year)

Earnings for Spero Therapeutics (SPRO)

Earnings in 2024 (TTM): -โ‚ฌ67.41 Million

According to Spero Therapeutics's latest financial reports the company's current earnings are โ‚ฌ27.39 Million. a decrease over its 2023 earnings that were of โ‚ฌ24.51 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Spero Therapeutics from 2017 to 2024

Annual earnings

Year Earnings Change
2024 -โ‚ฌ63.85 Million-360.42%
2023 โ‚ฌ24.51 M-163.53%
2022 -โ‚ฌ38.59 Million-50.14%
2021 -โ‚ฌ77.39 Million11.06%
2020 -โ‚ฌ69.69 Million25.15%
2019 -โ‚ฌ55.69 Million47.68%
2018 -โ‚ฌ37.71 Million5.61%
2017 -โ‚ฌ35.7 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚ฌ25.85 M-140.50%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ5.10 B-8,097.63%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.78 B-2,899.24%๐Ÿ‡จ๐Ÿ‡ฆ Canada